Jane Bradley Alavi
Emeritus Associate Professor CE of Medicine
Department: Medicine
Contact information
16 Penn Tower
399 S. 34TH ST.
4385
Philadelphia, PA 19104
399 S. 34TH ST.
4385
Philadelphia, PA 19104
Email:
jalavi@mail.med.upenn.edu
jalavi@mail.med.upenn.edu
Education:
A.B. (Chemistry)
Bryn Mawr College, 1962.
M.D.
Harvard University, 1966.
Permanent linkA.B. (Chemistry)
Bryn Mawr College, 1962.
M.D.
Harvard University, 1966.
Description of Research Expertise
Member of Editorial Board;American Journal of Clinical Oncology
Selected Publications
Batchelor T, Carson K, O’Neill A, Grossman S, Alavi J, New P, Hochberg F, and Priet R: Treatment of Primary CNS Lymphoma With Methotrexate and Deferred Radiotherapy: NABTT 96-07. Pro Am Soc Clin Oncol 21: 144p, 2003.Supko J, He X, Whitney C, Batchelor T, Mikkelsen T, Alavi J, Phuphanick S, Grossman S: Pharmacokinetics of Procarbazine and Metabolite Involved In Its Bioactivation In Patients with Recurrent Anaplastic Astrocytoma. Proc Am Soc Clin Oncol 21: 68b, 2002.
Alavi JB, Eck SE: Gene Therapy for High Grade Gliomas. Expert Opinion on Biological Therapy 1(2): 239-252, 2001.
Eck, SL, Alavi, JB, Judy, KD, Phillips, P, Alavi, A, Hackney D, Cross P, Hughes J, Gao, GP, Wilson JM, Propert K: Clinical Protocol. Treatment of Recurrent or Progressive Malignant Glioma with a Recombinant Adenovirus Expressing Human Interferon-Beta (H5.010CMVhIFN-B): A Phase I Trial. Human Gene Therapy 12(1): 97-113, 2001.
Balmaceda C, DeRosa C, Peterson K, Peerboom D, Alavi J, Fetell M, Krouwer H, Panullo S, Bagiella E, Weaver S, McAllister L, Heller L, Fine R: Multi-Institutional Trial of BID Regimen of Temozolomide for Recurrent Malignant Gliomas. Proc Am Soc Clin Oncol 20: 65a, 2001.
Stein S, Duarte PS, Alavi A, Zhuang H, Alavi, JB: Multiple intra abdominal soft tissue masses in a man awaiting liver transplantation: A Case Study and Discussion. Am J Clin Oncol, (CCT) 23(5): 506-508, 2000.
Newberg AB, Alavi A, Alavi JB: Contralateral Cortical Diaschisis in a Patient With Cerebellar Astrocytoma after Radiation Therapy. Clinical Nuclear Medicine 25(6): 431-433, 2000.
Alavi JB, Grossman SA, Jupko J, Carson K, Priet R, Dorr A, Holmlund J: Efficacy, Toxicity, and Pharmacology of an Antisense Oligonucleotide Directed Against Protein Kinase C- (ISIS 3521) Delivered as a 21 Day Continuous Intravenous Infusion in Patients with Recurrent High Grade Astrocytomas (HGA). Proc Am Soc Clin Oncol 19: 167a, 2000.
Batchelor TT, Hochberg FH, O’Neill, Alavi J, New P, Lesser G, Mikkelsen T, Grossman SA, Priet R, Carson K: The Treatment of Primary Central Nervous System Lymphoma (PCNSL) with Methotrexate and Deferred Radiotherapy: NABTT 96-07. Proc Am Soc Clin Oncol 19: 159a, 2000.
Batchelor TT, Hochberg FH, O’Neill, Alavi J, New P, Lesser G, Mikkelsen T, Grossman SA, Priet R, Carson K: The Treatment of Primary Central Nervous System Lymphoma (PCNSL) with Methotrexate and Deferred Radiotherapy. Neuro-Oncology 2: 250, 2000.